Scopolamine Sensitivity Testing
Objective: Assessment of sensitivity to cholinergic antagonist scopolamine injections during delayed nonmatching-to-sample performance to evaluate central cholinergic system function in basal forebrain lesioned monkeys
This is a Scopolamine Sensitivity Testing protocol using cynomolgus monkeys as the model organism. The procedure involves 3 procedural steps, 2 materials. Extracted from a 1994 paper published in Journal of Neuroscience.
Model and subjects
cynomolgus monkeys
Study window
Estimated timing pending
Core workflow
Baseline delayed nonmatching-to-sample task performance • Scopolamine injection • Delayed nonmatching-to-sample task performance assessment
Primary readouts
- Accuracy in delayed nonmatching-to-sample task following scopolamine injection
- Sensitivity to scopolamine (change in performance from baseline)
- Evidence of central cholinergic system compromise
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Baseline delayed nonmatching-to-sample task performance
Establish baseline accuracy in delayed nonmatching-to-sample task prior to scopolamine testing
Note: This establishes control performance against which scopolamine effects are measured
View evidence from paper
“BFCS lesions increased sensitivity to injections of the cholinergic antagonist scopolamine in a delayed nonmatching-to-sample task”
Scopolamine injection
Administer scopolamine injections to test sensitivity of cholinergic system
Note: Injection route, dose, and timing not specified in provided text
View evidence from paper
“BFCS lesions increased sensitivity to injections of the cholinergic antagonist scopolamine in a delayed nonmatching-to-sample task”
Delayed nonmatching-to-sample task performance assessment
Assess accuracy in delayed nonmatching-to-sample task following scopolamine injection to measure cholinergic antagonist effects
Note: Compare performance to baseline to determine sensitivity to scopolamine
View evidence from paper
“BFCS lesions increased sensitivity to injections of the cholinergic antagonist scopolamine in a delayed nonmatching-to-sample task, indicating that the central cholinergic system was compromised”